BioAdaptives Inc.

BDPT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2015 FY2014
Operating Activities
Net Income $-227.4K $-2.6M
Depreciation & Amortization
Depreciation $528 $527
Amortization
Stock-Based Compensation $1.6M
Net Cash from Operating Activities $-72 $-58.6K
Investing Activities
Capital Expenditures $-1.6K
Business Acquisitions
Net Cash from Investing Activities $-1.6K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $-37.7K $79.5K
Net Change in Cash $-37.8K $19.3K
Free Cash Flow $-57.0K
← Newer Page 2 of 2 Older →